SCHEMBL10011568

SCHEMBL10011568

CCOCCOC(=O)CO[Si](C)(C)C

nearest known ligand 0.52

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.52
TSHR P16473 3/20 0.52
THRB P10828 2/20 0.46
HSD17B10 Q99714 3/20 0.41
HPGD P15428 1/20 0.36
KMT2A Q03164 1/20 0.36
DGKA P23743 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.34
TP53 P04637 2/20 0.33
HIF1A Q16665 2/20 0.33
MGAM O43451 1/20 0.33
GAA P10253 1/20 0.33
SI P14410 1/20 0.33
MGAM2 Q2M2H8 1/20 0.33
EPHX2 P34913 1/20 0.33
NAAA Q02083 1/20 0.31
TRPA1 O75762 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL780053 0.83 ALDH1A1 (0.60) ALDH1A1TSHRTHRBHSD17B10HPGD
SCHEMBL10011308 0.81 HCAR2 (0.42) ALDH1A1TSHRHPGDDGKATP53
SCHEMBL17974553 0.81 ALDH1A1 (0.58) ALDH1A1TSHRTHRBHSD17B10HPGD
SCHEMBL10012033 0.81 GAA (0.52) ALDH1A1TSHRHSD17B10HPGDKMT2A
SCHEMBL9888985 0.79 ALDH1A1 (0.56) ALDH1A1TSHRTHRBHSD17B10HPGD
SCHEMBL10012783 0.79 TSHR (0.38) ALDH1A1TSHRDGKASMN1; SMN2
SCHEMBL21858311 0.78 GAA (0.41) ALDH1A1TSHRHSD17B10HPGDSMN1; SMN2
SCHEMBL10011059 0.78 ATM (0.52) ALDH1A1TSHRHPGDDGKANAAA
SCHEMBL18470076 0.78 ALDH1A1 (0.54) ALDH1A1TSHRTHRBHSD17B10HPGD
SCHEMBL20862115 0.78 ALDH1A1 (0.54) ALDH1A1TSHRTHRBHSD17B10HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9130244-B2 Nonaqueous electrolyte solution and electrochemical element using same UBE INDUSTRIES, LTD. (JP) 2015-09-08 US disclosed
EP-2908376-A1 NONAQUEOUS ELECTROLYTE SOLUTION AND ELECTROCHEMICAL ELEMENT USING SAME Ube Industries, Ltd. (JP) 2015-08-19 EP disclosed
EP-2479831-A1 NONAQUEOUS ELECTROLYTE SOLUTION AND ELECTROCHEMICAL ELEMENT USING SAME Ube Industries, Ltd. (JP) 2012-07-25 EP disclosed
US-20120171581-A1 NONAQUEOUS ELECTROLYTE SOLUTION AND ELECTROCHEMICAL ELEMENT USING SAME UBE INDUSTRIES, LTD. (JP) 2012-07-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120171581-A1 NONAQUEOUS ELECTROLYTE SOLUTION AND ELECTROCHEMICAL ELEMENT USING SAME SLC8A1, OR10J3, SLC8B1 ALDH1A1 2965/4885TSHR 3669/4885THRB 3670/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.